Epidemiology of Cancer: Prevalence, Incidence of Neoplastic Diseases and Trends in Survival in Europe



Geographically, Europe consists of 40 countries, some of them are members of the European Union. We examined the estimates of cancer incidence, mortality and 5-year survival for the four most frequent cancers representing about 50% of cancer burden in the European countries. The cancer burden and the increasing trends in incidence of the most common cancers in Europe are of concern, in particular those at younger ages. The differences in survival of patients with cancer are wide for patients diagnosed up to 2002, with the highest survival in northern and central Europe and the lowest survival in the UK and eastern Europe. The pattern observed suggests that further improvements could be made by applying proven treatment protocols and ensuring that all cancer patients have access to early diagnosis and high quality treatment. As a final point, we reported the 4th edition of the European Code against Cancer.



The authors wish to thank Mrs Luigina Mei for editorial assistance.


  1. 1.
    European Network of Cancer Registries. ►
  2. 2.
    Steliarova-Foucher E, O’Callaghan M, Ferlay J, et al. European cancer observatory: cancer incidence, mortality, prevalence and survival in Europe, version 1.0. European Network of Cancer Registries, International Agency for Research on Cancer. 2012. Available at ► Accessed 12 Sept 2015.
  3. 3.
    International Agency for Research on Cancer/World Health Organization. GLOBOCAN 2012. Estimated cancer incidence, mortality and prevalence worldwide in 2012. 2012. Available at ►
  4. 4.
    World Health Organization (WHO) Databank. Geneva, WHO Statistical Information System. 2015. Available at ► Accessed 12 Sept 2015.
  5. 5.
    United Nations, Population Division. World population prospects, the 2010 revision. 2010. Available from ► Accessed 12 Sept 2015.
  6. 6.
    Arnold M, Karim-Kos HE, Coebergh JW, et al. Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European cancer observatory. Eur J Cancer. 2015;51(9):1164–87.CrossRefPubMedGoogle Scholar
  7. 7.
    Bray F, Lortet-Tieulent J, Ferlay J, et al. Prostate cancer incidence and mortality trends in 37 European countries: an overview. Eur J Cancer. 2010;46(17):3040–52.CrossRefPubMedGoogle Scholar
  8. 8.
    Doll R, Payne P, Waterhouse J. Cancer incidence in five continents: a technical report. Berlin: Springer (for UICC); 1966.CrossRefGoogle Scholar
  9. 9.
    Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer. 2010;46(4):765–81.CrossRefPubMedGoogle Scholar
  10. 10.
    Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–403.CrossRefPubMedGoogle Scholar
  11. 11.
    Feuer EJ, Merrill RM, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer—part II: cause of death misclassification and the recent rise and fall in prostate cancer mortality. J Natl Cancer Inst. 1999;91(12):1025–32.CrossRefPubMedGoogle Scholar
  12. 12.
    Héry C, Ferlay J, Boniol M, et al. Quantification of changes in breast cancer incidence and mortality since 1990 in 35 countries with Caucasian-majority populations. Ann Oncol. 2008;19(6):1187–94.CrossRefPubMedGoogle Scholar
  13. 13.
    Torre LA, Bray F, Siegel RL, et al. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.CrossRefPubMedGoogle Scholar
  14. 14.
    Lortet-Tieulent J, Soerjomataram I, Ferlay J, et al. International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women. Lung Cancer. 2014;84(1):13–22.CrossRefPubMedGoogle Scholar
  15. 15.
    Malvezzi M, Bertuccio P, Levi F, et al. European cancer mortality predictions for the year 2012. Ann Oncol. 2012;23(4):1044–52.CrossRefPubMedGoogle Scholar
  16. 16.
    De Angelis R, Sant M, Coleman MP, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE—5-a population-based study. Lancet Oncol. 2014;15(1):23–34.CrossRefPubMedGoogle Scholar
  17. 17.
    Anderson AS, Key TJ, Norat T, et al. European code against cancer 4th edition: obesity, body fatness and cancer. Cancer Epidemiol. 2015;39 Suppl 1:S34–45.CrossRefPubMedGoogle Scholar
  18. 18.
    Arnold M, Pandeya N, Byrnes G, et al. Global burden of cancer attributable to high body-mass index in 2012: a population-based study. Lancet Oncol. 2015;16(1):36–46.CrossRefPubMedGoogle Scholar
  19. 19.
    Blackadar CB. Historical review of the causes of cancer. World J Clin Oncol. 2016;7(1):54–86.CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Friis S, Kesminiene A, Espina C, et al. European code against cancer 4th edition: medical exposures, including hormone therapy, and cancer. Cancer Epidemiol. 2015;39 Suppl 1:S107–19.CrossRefPubMedGoogle Scholar
  21. 21.
    Hakulinen T, Arbyn M, Brewster DH, et al. Harmonization may be counterproductive—at least for parts of Europe where public health research operates effectively. Eur J Public Health. 2011;21(6):686–7.CrossRefPubMedGoogle Scholar
  22. 22.
    Harris HR, Bergkvist L, Wolk A. Adherence to the world cancer research fund/American institute for cancer research recommendations and breast cancer risk. Int J Cancer. 2016. doi: 10.1002/ijc.30015 [Epub ahead of print].Google Scholar
  23. 23.
    International Agency for Research on Cancer (IARC). Monographs on the evaluation of carcinogenic risks to humans, Tobacco smoke and involuntary smoking, vol. 83. Lyon: IARC; 2004.Google Scholar
  24. 24.
    Leitzmann M, Powers H, Anderson AS, et al. European code against cancer 4th edition: physical activity and cancer. Cancer Epidemiol. 2015;39 Suppl 1:S46–55.CrossRefPubMedGoogle Scholar
  25. 25.
    Leon ME, Peruga A, McNeill A, et al. European code against cancer, 4th edition: tobacco and cancer. Cancer Epidemiol. 2015;39 Suppl 1:S20–33.CrossRefPubMedGoogle Scholar
  26. 26.
    Nomura SJ, Inoue-Choi M, Lazovich D, et al. WCRF/AICR recommendation adherence and breast cancer incidence among postmenopausal women with and without non-modifiable risk factors. Int J Cancer. 2016. doi: 10.1002/ijc.29994 [Epub ahead of print].PubMedCentralGoogle Scholar
  27. 27.
    Soerjomataram I, de Vries E, Pukkala E, et al. Excess of cancers in Europe: a study of eleven major cancers amenable to lifestyle change. Int J Cancer. 2007;120(6):1336–43.CrossRefPubMedGoogle Scholar
  28. 28.
    Vieira AR, Abar L, Vingeliene S, et al. Fruits, vegetables and lung cancer risk: a systematic review and meta-analysis. Ann Oncol. 2016;27(1):81–96.CrossRefPubMedGoogle Scholar
  29. 29.
    Wang J, Yang DL, Chen ZZ, et al. Associations of body mass index with cancer incidence among populations, genders, and menopausal status: a systematic review and meta-analysis. Cancer Epidemiol. 2016;42:1–8.CrossRefPubMedGoogle Scholar
  30. 30.
    World Cancer Research Fund international. Available at ► Accessed 09 Mar 2016.
  31. 31.
    Armaroli P, Villain P, Suonio E, et al. European code against cancer, 4th edition: cancer screening. Cancer Epidemiol. 2015;39 Suppl 1:S139–52.CrossRefPubMedGoogle Scholar
  32. 32.
    Moss SM, Nyström L, Jonsson H, et al. The impact of mammographic screening on breast cancer mortality in Europe: a review of trend studies. J Med Screen. 2012;19 Suppl 1:26–32.CrossRefPubMedGoogle Scholar
  33. 33.
    Minozzi S, Armaroli P, Espina C, et al. European code against cancer 4th edition: process of reviewing the scientific evidence and revising the recommendations. Cancer Epidemiol. 2015;39 Suppl 1:S11–9.CrossRefPubMedGoogle Scholar
  34. 34.
    Schüz J, Espina C, Villain P, et al. European code against cancer 4th edition: 12 ways to reduce your cancer risk. Cancer Epidemiol. 2015;39 Suppl 1:S1–10.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing Switzerland 2017

Authors and Affiliations

  1. 1.Unit of Cancer EpidemiologyCentro di Riferimento Oncologico, IRCCSAvianoItaly

Personalised recommendations